Motley Fool Staff

On the plus side, they limit your risks. On the minus side, there’s everything else about them.

Listener Rob wants to sell assets with low cost bases but doesn’t relish the tax bill that would create.

Listener Jeff is leaving the W-2 employee life behind and entering the fun and exciting world of being an independent contractor.

Listener Sean added GM to his portfolio based on its electric vehicle and ride share plans, but he's feeling a little concerned about his choice.

The asset management firm cofounder is urging caution in his annual letter.

Our analysts share their advice on investing through a far-reaching trade war, for the short and long term.

The tariffs probably aren’t going away anytime soon.

Some companies are getting hit harder by the U.S.-China trade war than others, and the most affected industries might surprise you.

Why two of the biggest market forces in the world are entering into a trade war with each other.

In case you missed it: Find out what a tariff is, what’s going on between the U.S. and China, and how far this reaches.

This fast-growing biotech is on track for significant earnings growth.

A small biotech is on the cusp of a big market opportunity.

Data from a highly anticipated trial shows a remarkable ability to reduce the risk of heart attack or stroke.

Listener Jay realizes he's been buying and selling based more on hopes and a compelling story than on data, real revenue, and such, and he's looking to change that.

The owner of Arby's and Buffalo Wild Wings thinks the drive-in chain will be a good fit for its portfolio.

And what does this luxury brand acquisition signal about the company's strategy?

Why we're interested in a REIT and a fintech giant.

Square is becoming a lot more than a payment-processing company.

The average homeowner's equity is up by a five-figure sum over the past year alone.

The e-commerce titan could offer a checking account product of its own, but will there be even more to come?